Novavax amends Australia COVID vaccine agreement; cancels doses, credits $31M, extends to 2029

NOVAVAX INC

Amendment #5 cancels certain COVID vaccine doses scheduled for delivery Q4 2023 through Q4 2025.
Approximately $31M of advanced payment credited against outstanding invoices and future delivery of ~3M doses.
Updated delivery schedule allows potential delivery of vaccine through end of 2029.
Commonwealth granted remedies for missed deliveries, regulatory approval failures, or notification lapses.
No additional cash payments required for future doses under the amendment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.